
Opinion|Videos|June 25, 2024
Key Takeaways on mBC and eBC
Key opinion leaders (KOLs) provide key takeaways on metastatic breast cancer and early breast cancer, emphasizing the enthusiasm surrounding recent advances in the field and the potential for improved patient outcomes.
Advertisement
Episodes in this series

Video content above is prompted by the following question(s):
- What are your key takeaways on the evolving treatment landscape for metastatic breast cancer and early breast cancer?
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Unproven Hantavirus Treatments Flood Social Media
2
Ketamine’s Expanding Role in Chronic Pain and Opioid-Sparing Therapy
3
FDA Expands Respiratory Options With First Single-Inhaler Triple Therapy for Asthma Maintenance
4
Navigating GLP-1 Access: A Pharmacy Technician’s Role
5





































































































































